Table IV. Main clinical features of Fabry patients at follow-up.
| # | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| Patient | FC* | FbV† | GC | MR‡ | MG¶ | GS | FS** | GS** | IS** | AC* | FaV† | AMC¶ | MTM* | GS** | RSv | MC¶ | AP | AC | SG | RR‡ |
| Sex | m | m | m | m | m | m | m | m | m | m | m | f | f | f | f | f | f | f | f | f |
| Angiokeratoma | + | + | ++ | – | + | +++ | ++ | + | – | – | + | + | + | + | – | – | – | + | + | – |
| Pain | ++ | ++ | + | + | + | +++ | +++ | + | + | + | ++ | ++ | + | ++ | + | + | – | ++ | – | – |
| Crisis of fever | – | ++ | – | – | – | +++ | + | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Vascular skin lesions | – | + | + | – | – | ++ | ++ | – | – | + | + | + | – | – | – | + | – | + | – | + |
| Ocular feature | + | + | + | + | + | ++ | ++ | + | ++ | + | – | + | ++ | + | – | – | + | + | – | – |
| Renal failure | + | ++ | +++ | ++ | + | + | +++ | + | + | +++ | + | +++ | – | + | ++ | + | + | + | – | – |
| Hypertrophic cardomyopathy | + | – | + | + | ++ | + | ++ | – | – | + | – | + | ++ | – | + | – | – | – | + | + |
| Lymphoedema | ++ | ++ | – | + | – | +++ | + | + | – | + | ++ | – | – | – | – | + | – | + | – | + |
| CNS TIA | – | + | – | – | + | – | – | – | – | – | – | – | + | – | – | – | – | – | – | – |
*, †, ‡, ¶, **: relatives; CNS: central nervous system; TIA: transient ischaemic attack; sign/symptom severity: – none; + mild; ++ moderate; +++ severe.